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ABSTRACT
Zona pellucida (ZP) glycoproteins have been proposed as
candidate antigens for immunocontraception. Studies on this
potential use can be facilitated by the availability of recombi-
nant proteins. A cDNA gt11 library was constructed using
poly(A) + mRNA isolated from bonnet monkey (Macaca radiata)
ovaries and was screened for bonnet monkey ZP1 using a 404-
basepair (bp) human ZP1 fragment (nucleotides 818-1221) as
probe. Bonnet monkey ZP1 cDNA comprises 1617 nucleotides
and encodes a polypeptide of 539 amino acid residues that share
92.0% identity with human ZP1. The major difference between
bonnet monkey ZP1 and human ZP1 is the deletion of a 28-ami-
no acid domain (amino acid residues 100-127 corresponding to
human ZP1). An internal fragment (1317 bp) of bonnet monkey
ZP1, excluding the N-terminus signal sequence and the C-ter-
minus transmembrane-like domain, was amplified by polymer-
ase chain reaction. The amplified Sac I and Kpn I restricted frag-
ment was cloned in a frame downstream of the T5 promoter
under the lac operator control for expression in the pQE-30 vec-
tor. Recombinant ZP1 (r-ZP1) was expressed as a polyhistidine
fusion protein in Escherichia coli strains SG13009[pREP4] and
ompT and Ion protease-deficient BL21 (plysS). SDS-PAGE analy-
sis and immunoblotting with a murine monoclonal antibody,
MA-410 (raised against porcine ZP3ao-a homologue of bonnet
monkey ZP1 -and cross-reactive with bonnet monkey zona pel-
lucida), revealed major bands of 51 and 40 kDa besides trun-
cated fragments. Optimum expression of r-ZP1 was observed at
0.5 mM isopropyl -D-thiogalactopyranoside (IPTG). Immuni-
zation of male rabbits with r-ZP1 purified on nickel-nitrilotri-
acetic acid (NTA) resin under denaturing conditions and of fe-
male rabbits with r-ZP1 conjugated with diphtheria toxoid-gen-
erated antibodies reactive with r-ZP1 in ELISA. Moreover, im-
mune sera, when tested by indirect immunofluorescence on
bonnet monkey ovarian sections, showed positive fluorescence
with zona pellucida. The information on the sequence of bonnet
monkey ZP1 and the availability of the recombinant protein will
help toward better understanding and evaluation of the contra-
ceptive potential of homologous immunization in a nonhuman
primate model.
INTRODUCTION
The recognition and binding of sperm by the extracel-
lular glycoprotein coat of the mammalian egg, the zona
pellucida (ZP), initiates the fertilization process. Gamete
adhesion is mediated by complementary molecules on the
respective surfaces of sperm and ZP [1]. This critical role
during fertilization has made the ZP glycoproteins potential
candidate antigens for immunocontraception. ZP in most
species comprises three biochemically and immunological-
ly distinct glycoproteins-ZP1, ZP2, and ZP3. On the basis
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of the size of their mRNAs, these have been also classified
as ZPA (ZP2), ZPB (ZP1), and ZPC (ZP3); ZPA is the
longest and ZPC the shortest [2]. In the mouse, the three
zona transcripts have been detected only in the ovary, in
which their expression is restricted to oocytes [3-5]. How-
ever, in cynomolgus monkeys, ZP2 and ZP3 transcripts are
present not only in oocytes at all stages of folliculogenesis
but also in granulosa cells [6]. In contrast, the ZP1 tran-
script is present in oocytes in secondary follicles and to a
lesser extent in tertiary follicles but is absent in primordial,
primary, or antral follicles and granulosa cells [6]. ZPI has
been cloned and sequenced from humans [2], mice [7], rab-
bits [8], pigs [9], and cats [2]. To avoid or minimize ovarian
dysfunction from a ZP glycoprotein-based immunocontra-
ceptive vaccine for human application, it is desirable that
the candidate antigen not be present on the primordial/pri-
mary follicles and granulosa cells. Moreover, it will be de-
sirable to use either human zona proteins or those with a
high sequence homology with human zona proteins and
available in pure form without contamination of other ovar-
ian-associated antigens. Keeping this in view, in this com-
munication we describe cloning and sequencing of bonnet
monkey (Macaca radiata) ZP1 and strategies for its ex-
pression in a prokaryotic system. The ability of the recom-
binant ZPI (r-ZPI) to generate an antibody reactive to the
native protein is also investigated.
MATERIALS AND METHODS
Bonnet Monkey Ovarian cDNA Library, and Screening
and Sequencing of ZPI Clones
Ovaries were collected from a 2-yr-old female bonnet
monkey, snap-frozen in liquid nitrogen, and stored at
-70°C until used. Total RNA was isolated from frozen ova-
ries, and the poly(A)+ fraction was purified by using the
polyATtract mRNA isolation system (Promega, Madison,
WI). Complementary DNA was synthesized from the pu-
rified poly(A)t RNA by using a cDNA synthesis system
(Riboclone; Promega) and was cloned in Xgtl 1 to construct
a library (Packagene Lambda DNA Packaging System; Pro-
mega). The Xgtl 1 ovarian cDNA library was screened us-
ing a human 404-base pair (bp) ZP1 fragment (nucleotides
818-1221; kindly provided by Dr. Jurien Dean, Laboratory
of Cellular and Developmental Biology, National Institutes
of Health, Bethesda, MD). An insert from each positive
clone was amplified by polymerase chain reaction (PCR)
by means of Xgtll forward (5'-GGTGGCGACGA-
CTCCTGGAGCCCG-3') and reverse (5'-TTGACACCA-
GACCAACTGGTAATG-3') primers; this involved an ini-
tial melt at 94°C for 10 min and 30 cycles at 94°C for I
min, 58°C for 2 min, and 72°C for 3 min, followed by a
final extension at 72°C for 15 min. The PCR amplification
was carried out in 50 xld final reaction volume with Taq
polymerase (Stratagene, La Jolla, CA). The amplified
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cDNA fragment was resolved by electrophoresis and puri-
fied by use of the GenecleanII kit (Bio 101 Inc., La Jolla,
CA). The product was cloned in pCRScript SK(+) cloning
vector (Stratagene) and sense-strand sequenced using T3
(5'-AATTAACCCTCACTAAAGGG-3') and T7 (5'-
GTAATACGACTCACTATAGGGC-3') primers by the di-
deoxy chain termination method [10] using Sequenase Ver-
sion 2.0 DNA sequencing kit (USB, Amersham Life Sci-
ences Inc., Buckinghamshire, UK). The complete sequence
of the insert was determined by following two different
strategies: 1) digesting the insert with EcoRI and cloning
EcoRI-digested fragments into pCRScript SK(+) followed
by sequencing; and 2) sequencing the full insert by design-
ing and synthesizing internal primers. The amino acid se-
quence was derived using the DNASIS program (Pharmacia
LKB Biotechnology AB, Bromma, Sweden). Various char-
acteristics of the ZP1 sequence were analyzed by PCGene
(IntelliGenetics, Inc., Mountain View, CA). The multiple
alignment of the ZP1 amino acid sequence of different spe-
cies with the bonnet monkey ZP1 sequence was carried out
using the Clustal V Multiple Alignment Program [11].
Expression of Bonnet Monkey ZP1 cDNA in Escherichia
coli
An internal fragment of the cDNA, excluding the signal
sequence and the transmembrane-like domain and follow-
ing the putative furin cleavage site, was amplified by PCR
using the forward primer 5'-GGTGAGCTCAAGCCTGA-
GACACCAGGT-3', incorporating a Sac I site, and the re-
verse primer 5'-TCTGGTACCGAGATCAGGACAGGT-
3', incorporating a Kpn I site. The PCR was done in a 50-p11
of final reaction volume using 50 pmol of each primer and
Vent polymerase (NEB Inc., Beverly, MA) for extension.
The pBluescript-ZP1 (clone 5, 10 ng) was used as the tem-
plate and was initially denatured at 95°C for 10 min. Am-
plification was carried out for 30 cycles of denaturation at
94°C for 1 min, primer annealing at 55°C for 2 min, and
extension at 72°C for 3 min, followed by a final extension
at 72°C for 15 min. The amplified 1.317-kilobase (kb) frag-
ment was digested with Sac I and Kpn I and cloned in a
frame downstream of a 6X histidine tag under the T-5 pro-
moter-lac operator control in the pQE-30 vector (QIAex-
press; Qiagen GmbH, Hilden, Germany). The pQE-ZP1
plasmid was transformed in SG13009[pREP4] bacterial
strains provided with the kit. In addition, BL21(plysS) cells,
deficient in omp T and lon proteases, were also transformed
with the pQE-ZPl plasmid.
For expression of r-ZP1 cloned in the pQE-30 vector, a
single transformed colony was inoculated and grown over-
night at 37°C in 1 ml of Luria Broth (Difco Laboratories,
Detroit, MI) containing 100 txg/ml of ampicillin and 25
jpg/ml of kanamycin. The next morning, cells were sub-
cultured 1:10 and grown until cell density reached an ab-
sorbance at 600 nm (A600) of approximately 0.6-0.7. The
cells were further grown in the presence of isopropyl 3-D-
thiogalactopyranoside (IPTG) to induce expression of the
fusion protein under the T-5 promoter. Conditions with re-
spect to the time and IPTG concentration used for induction
of r-ZP1 were standardized. The cells were collected by
centrifugation at 13 000 x g for 60 sec, and the resulting
pellet was stored at -70°C until used.
SDS-PAGE and Immunoblotting
The cell pellet obtained from 1 ml culture was solubi-
lized by boiling for 5 min in 100 R.1 of double-strength
sample buffer (0.0625 M Tris [pH 6.8], 2% SDS, 10% glyc-
erol, 5% -mercaptoethanol, and 0.001% bromophenol
blue), and the proteins were resolved on a 0.1% SDS-10%
polyacrylamide gel [12]. The proteins were electrophoret-
ically blotted to 0.45-pxm nitrocellulose membrane (Bio-
Rad, Hercules, CA) overnight at a constant voltage of 15
V in Tris glycine buffer with 20% methanol [13]. For im-
munoblotting, nonspecific sites on the membrane were
blocked by incubation with 5% BSA in 50 mM PBS (pH
7.4) for 1 h and then washed 3 times (15 min each) with
PBS containing 0.1% Tween-20 (PBST). For detection of
bonnet monkey r-ZP1, a murine monoclonal antibody
(mAb), MA-410, generated against porcine ZP3ao (a ho-
mologue of bonnet monkey ZP1) and immunologically
cross-reactive with bonnet monkey ZP, was used. The mem-
brane was incubated for 1 h with a 1:5 dilution of MA-410
culture supernatant and washed 3 times in PBST Horserad-
ish-peroxidase (HRP)-conjugated goat anti-mouse immu-
noglobulin (Ig; Bio-Rad) were used to reveal bound anti-
body. Color was developed with 0.6% (w:v) 4-chloro-nap-
thol in 50 mM PBS containing 25% methanol and 0.06%
H2 0 2. The reaction was stopped by washing the membrane
with PBS.
Purification and Conjugation of r-ZP1 with Diphtheria
Toxoid (DT) and Immunization
For purification of r-ZP1 fusion protein, SG13009[pREP4]
cells transformed with the PQE-ZP1 r-plasmid were grown at
the shaker flask level (250 ml culture/flask; total volume 2 L).
Cells were pelleted at 1500 x g for 30 min at 40C and stored
at -70°C until used. The cell pellet (1 g) was solubilized in
5 ml of buffer A (6 M guanidine hydrochloride, 0.1 M
NaH 2PO4, 0.01 M Tris, pH 8.0). The suspension was centri-
fuged at 10 000 x g for 5 min at 4°C, and the supernatant
containing the recombinant fusion protein was mixed with
gentle end-to-end shaking for 1 h at room temperature (RT)
with nickel-nitrilotriacetic acid (NTA) resin (Qiagen GmbH).
The resin was loaded onto a column and washed with 5 vol-
umes of buffer A. The column was subsequently washed with
5 volumes each of buffers B and C, which contained 8 M
urea, 0.1 M NaH2PO4, and 0.01 M Tris and had successively
reducing pH values of 8 and 6.3, respectively. The recombi-
nant fusion protein was eluted with buffers D and E (of com-
position identical to buffers B and C), in which the pH was
further reduced to 5.9 and 4.5, respectively. The eluted protein
was concentrated in an Amicon concentrator using a YM5
membrane (Amicon Corp., Lexington, MA) and then dialyzed
against 100 mM phosphate buffer (pH 7.4) containing 4 M
urea. The purified protein was quantified with bicinchoninic
acid (Sigma Chemical Co., St. Louis, MO). Five milligrams
of r-ZP1 was conjugated to 2.5 mg of DT (Serum Institute,
Pune, India) using the "one-step" glutaraldehyde coupling
procedure [14]. Conjugation was done in 100 mM phosphate
buffer, pH 7.4, with 4 M urea using 0.1% glutaraldehyde,
overnight at RT with gentle end-to-end mixing. Unreacted
sites were blocked with 100 mM lysine for 3 h at RT The
conjugate was dialyzed against 10 mM PBS with 0.3 M urea.
Two 6-mo-old male New Zealand white rabbits (Small
Experimental Animal Facility, National Institute of Immu-
nology, New Delhi, India) were immunized intradermally
at multiple sites with 200 tpg of r-ZPl, emulsified in com-
plete Freund's adjuvant. The animals received i.m. boosters
after 4 wk with an equivalent amount of r-ZP1 in incom-
plete Freund's adjuvant. In addition, two 6-mo-old female
New Zealand white rabbits were also immunized with
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BoC5 ATGCGGCTGCTGCAGTGTGTCTTGCTTGTGTTTCATTATCTCTTGTTTAGTGGTC 58
............ ** *****.* ** ** 
BoC25
BoC5 AGCATAAGCCTIAGACACCAGGTTATTCCAGTGTCTCCATTGTGGCTGTGGAGCTT 116
BoC25
BoC5 CCAGTTTGCTGTAAACCTCAGTCAGGAGGCAACTTCTCCTCCTTACTAATAACTTG 174
BoC25................ .....................****
BoC5 OACAACCAAGGGCTOCTGCACAAGCTACACAATGACTCTGACTGTGGCACCTGGATAA 232
.*** ..**.****.*****.** -. ...........................*
BoC25 ********************************.... *
BoC5 GAAAACGTCCACIGCAGCTCCGTGGTGTTGGAGGCAACCTATAGCAGCTCTATGTCAC 290
BoC25****C**************................................*.**.*.....*****.....*.
BoC5 TGAGTGGACTCCCACTACATCATGCCAGTTGAGTTCGAAGGAGTGG TGTGGCTGAA 348
BoC25***** .............* ....***... .......*. .BC25***************** .... ..................... ***.**** ........ *.*.*
BoC5 *ACAGAOTGGTCTCCAGAGAGAAGCTGCTCAAGTGTCTATGATCTTCTACCCGAG 406
BoC25* ***** T******* *** *********************************
BoC5 ATGCTCCAGATACTATGGTGTGACTCCATCCCAGCGCGGGACAGGCTGCCATGTGC 464
********** ***************************TA*TG*TAGTGACC*CGC
BC25** ****************************************************
BoC5 ACCTTCACCATCTCTCGAGGAGACTGTGAGGCTAGGCTGCTGTTACAGCTCTGA. 522
T'G*GGA'C'
BoC2*. ***********'**......********A- ... -*************G
BoC5 ..... GATTCCTGCTACTAICGACAC CCGTGACCTTGGTTGTACCCGA.AGGGCC 580
BoC25GAGGT* ************* ** ******** 
BoC5 AMTTCTCGATCGCTTGTCTCGGAACGTGGTCTCGCACCAC TGCTCTTGGATTCTGT 638
BoC2 ******************************************************
BoC5 GCGCTTGGCCCTTAGGAATGACAGTGCGTGTAACCCTGTGATGGCAACACAAGCTTTT 696
BoC25.**************... ***
BoC5 GTTCTGTTCCATTTTCCATTTACTTCCTGTGGCACCACGACGGATCACTGGAACC 754
BoC25********************************-***********************
BoC5 GAGCAGTATACGAAAATGAACTGGTGCOACTAGGGATGTGAAAAATGOGAGCCGTG 812
B*C25******** ......******** .************
Bo5 CTCTGTCC TCGTACAGCATCTTCAGGCTCATGTCAGCTGCAGCTACTCAGTAAGT 870
BoC25*** .*********.****..* * *  * ..
BoC5 AGCAATCCCCCTCCCAATCAAGGTCCAGGTTTTTACTCTCCCACACCCTTCCTGAGA 928
BoC25l*************....*** ** .****
BCS CCCAGCCTGGACCCCTCACTTGGAACTTCAGATTGCCAAAGATAAAAACTATGGCTC 986
B0C25 **************.*******
BoC5 CTACTATGTGTTGTGACTACCCCGTGGTGAAGTTGCTTCGGGATCCCATCTATGTG 1044
BoC2* *** ***** ******* ********* *******
BoC5 GAGGTCTCCATCCTTICACAGAACAGACCCCTCCCTGGGGCTGCTCCTACATAGTGTT 1102
BoC5 GGGCAACACCCAGCACAGACCCACTGAGTCAGCCACAGTGGCCCATCCTGGTAAAGGG 1160
BoC25 ******************  
BoC5 CTGTCCCTACATTGGAGACAACTATCAGACCCAGCTGATCCCTGTCCAAAAGCCTTG 1218
BoC25***C*************** ***
BoC5 GATCTTCCATTTCCCTCTCACTACCAGCGCTTCAGCATCTTCACCTTCAGTTTGTGG 1276
BoC2* ******************************************************
BoC5 ACCCTACAGTGGAGAAACAGGCCCTCAGGGGACCGGTGCATCTGCACTGCCAGTGTGTC 1334
BoC25******************************************************
BoC5 AGTCTGCCAGCCTGCTGAGACACCATCATCTGTGCGTACCTGTCCTGATCTCAGTCGA 1392
BoC2 ***''*********** **C *****'** ***********
BoC5 AGAAGAAAATTCAGCACCATTTTTCAGAACAC CTGCTAGTGTTTCTA GCAAAGGCC 1450
BoC25..******T*CAG *************************
BoC5 CCATGATTCTACTCCAACCACTAAGGACCCTCCAGAAAAGCTCCGTGCTCC GTAGA 1508
BoC2 ** . *********.*****
BoC5 CTCAAAAGTTCTGTGGGTGGCAGGCCTTTCTGGGACCTTAATCCTTGGAGGCTTAGTA 1566
BoC25* * *** ***********. ****..........  **
BoC5 GTATCCTACTGGCTATCAACAGCTGAArGTCCAGACCAAAATGTCAATAAAAC 1624
BoC25 **** ********* ***.**...****... ***.......-***.......
BoC5 AGCTGTACTCCAAAAAAAAACCGGAATTCCGCC 1659
BoC25***'*****
FIG. 1. Nucleotide sequence of bonnet monkey ZP1 cDNA clones 5
(BoC5) and 25 (BoC25). Line 2 under BoC5 represents a 474-nucleotide
repeat fragment that precedes the remaining sequence of the BoC5 clone.
The BoC25 sequence starts at nucleotide 149 after ATG. The putative
nucleotide 63 signal sequence is underlined, and the arrow after 63 nt
points to the predicted signal peptidase cleavage site. The predicted furin
cleavage site is denoted by overlining. Asterisks represent conserved nu-
cleotides with respect to clone 5, and dots represent the deletion of nu-
cleotides in the respective clones. The nucleotide sequence data reported
in this figure will appear in the EMBL, GenBank, and DDBJ nucleotide
sequence databases under accession numbers Y10381, Y10382, and
Y10383.
r-ZP1-DT conjugate (equivalent to 200 jig r-ZPl/animal)
according to the procedure described for the male rabbits.
Seven days after the booster, animals were bled to charac-
terize the antibody response.
ELISA
Reactivity of anti-r-ZP1 antibodies was tested by a direct
binding ELISA. Microtitration plates were coated with ei-
ther 200 ng of r-ZP1 (for which 1 mg stock r-ZPI in 100
mM phosphate buffer, pH 7.4, with 4 M urea was diluted
in 50 mM PBS, pH 7.4) or 500 ng of DT per well in 50
mM PBS, pH 7.4, were incubated for 1 h at 370 C and then
overnight at 40C. All subsequent incubations were at 37°C
for 1 h. After each incubation, the plates were washed three
times in 50 mM PBS containing 0.05% Tween-20. Plates
were blocked with 1% BSA. After blocking, 100 p1l of dou-
bling dilutions of the preimmune and immune serum sam-
ples were added in duplicate. HRP-conjugated goat anti-
rabbit Ig (Pierce, Rockford, IL) at a 1:5000 dilution was
used as revealing antibodies. Enzyme activity was detected
by adding 100 1l of 0.05% orthophenylene diamine and
0.06% H2 02 in 50 mM citrate phosphate buffer (pH 5.0)
to each well, and the reaction was stopped by adding 50
pil/well of 5 N H2SO4 . A49 2 was read, and antibody titers
were calculated by regression analysis. Antibody titer is
expressed as antibody unit, i.e., the dilution of serum giving
an absorbance of 1.0.
Immunofluorescence on Bonnet Monkey Ovarian
Sections
A normal cycling female monkey (10 yr old) was ovar-
iectomized, and the ovaries were snap-frozen in liquid ni-
trogen. Sections of 5-pxm thickness were cut in a cryostat
at -20°C and fixed for 20 min in chilled methanol. Sections
passing through a follicle were selected, washed in PBS,
and blocked for 30 min in 5% normal goat serum. The
sections were incubated at 37°C with a 1:2000 dilution of
rabbit preimmune and immune sera for 1 h, washed with
PBS, and incubated for 1 h with a 1:1000 dilution of goat
anti-rabbit Ig-fluorescein isothiocyanate (FITC) conjugate
(Pierce). Slides were washed with PBS, mounted in glyc-
erol:PBS (9:1), and examined under a fluorescent micro-
scope (Optiphot; Nikon, Chiyoda-Ku, Tokyo, Japan).
RESULTS
Nucleotide Sequence of cDNA Encoding Bonnet Monkey
ZP1
The constructed bonnet monkey ovarian cDNA Xgtll
library had 1.79 X 106 independent plaques with 96% re-
combinant before amplification. Six positive clones were
obtained by plaque hybridization of an amplified library
with a 404-bp fragment of human ZP1 cDNA. Amplifica-
tion of the insert by PCR using Xgtl 1 forward and reverse
primers and its analysis by electrophoresis revealed one
clone (clone 5, BoC5) to be 2.1 kb, two clones (clones 23-
BoC23 and 25-BoC25) 1.6 kb, and three clones (clones
22, 24, and 28) smaller than 1.6 kb (data not shown). The
PCR-amplified product from three clones (5, 23, and 25)
was cloned into pCRScript SK(') vector. Sequences from
both ends of these three fragments revealed that clone 5
had a full-length cDNA with both the translation initiation
codon (ATG) and the termination codon (TAA) along with
the poly(A) tail at the 3' end. Clones 23 and 25 had the
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translation termination codon but not the translation initi-
ation codon.
Further mapping of clone 5 with EcoRI resulted in 4
fragments of -750, -550, -500, and -250 bp. Nucleotide
sequence analysis revealed that both the -500-bp (474 nt)
and the -550-bp fragments had a translation initiation co-
don. The -500-bp fragment had a sequence identical to
that of the -550-bp fragment (except 42 bp at the 3'-end).
The -550-bp fragment had a Xho I restriction site, and one
additional site was also present in the pCRScript SK(+)
vector. Digestion of clone 5 with Xho I generated two frag-
ments of 3.9 and 1.2 kb, indicating that the -550-bp frag-
ment was 3' to the -500-bp fragment. Hence, the order of
the various fragments in clone 5 was 5'---500 bp, -550
bp, -750 bp, -250 bp-3'. Figure 1 shows the nucleotide
sequences, within the limit of PCR errors, of clone 5 and
25. The nucleotide sequence of clone 23 was identical to
that of clone 25 and hence is not presented in Figure 1.
Clone 25 could be read only from 148 bp after ATG and
was identical to clone 5 except for 6 extra nucleotides at
nucleotide 521 and deletion of three nucleotides after nu-
cleotide 1391. Bonnet monkey ZP1 had a single open read-
ing frame of 1617 nucleotides, resulting in a polypeptide
core 539 amino acids in length with a calculated molecular
weight of 59 497. A potential signal peptidase site with
amino acids at the -1 and -3 positions that are in accor-
dance with the rule proposed by von Heijne [15] was found
after 21 amino acids in bonnet monkey ZP1. Comparison
of the deduced amino acid sequence of clone 5 with that
of human, rabbit, pig, cat, and mouse ZP1 is shown in
Figure 2. For this comparison, the sequence of the trans-
lation of the extra -500-bp 5' fragment of BoC5 was ex-
cluded because 11 of 13 amino acids at the C terminus were
different from those in human ZP1 (only 2 amino acids
differed in the -550-bp fragment). Furthermore, amino ac-
ids E and V at positions 175 and 176, which are present in
clones 23 and 25 but deleted in clone 5, were included for
this comparison. Comparison of the amino acid sequence
revealed that bonnet monkey ZP1 had a 28-amino acid de-
letion from amino acids 100-127 as compared to human
ZP1 (Fig. 2). The bonnet monkey ZP1 amino acid sequence
showed 92.0% identity with human ZP1. The mature pro-
tein, excluding the N-terminal signal sequence region and
the C-terminal transmembrane-like domain, which would
presumably be processed in a mature molecule, had an
identity of 93.7% with the corresponding human protein.
Amino acid sequence identity with rabbit ZP1 was 65.7%,
pig 62.3%, cat 65.1%, and mouse 36.9% (Fig. 2). Out of
539 amino acids, 131 were conserved in all 6 species (Fig.
2; marked by dashes in the space below the sequences).
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HUM --------------- ** **--********************* 187
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CAT QALV----SSLSPSPV*NV*LE**N--A*L***V*KW******S***TQ* 198
PIG ----------------- I*V*.-- **AV*W*******P**TQ* 161
MOU HTVPHSQWGTLEPWELTE*DSVGTHLPQZR*QVAS--GHI**MVGS*KE 245
BMON DCEGLGCCYSSEVNSCYYGNTVTLRCTRZGHFSIAVSRNVVSPPLLLDS 212
HM *************************** H*************f******** 237
RAB *2*** ******--**** ******* **************S******* 210
CAT * ** * ** **-*********************** ******** 247
PIG E*RQ********** *************±* ******* 211
MO A*QQA****D*TKEP**********Q*FRF*Y*TLVM*QETALTHV**M 295
BOM VRLALRDACNPV1ATQAFVLFHFPFTSCGTTRRITGDRAVYNELVAT 262
HM **** *******************Q****** ************* *** 287
RAB **VFG***E*Q**V**R************Q*****************L** 260
CAT L****FG R*****A**r****** **** **Q*********A 297
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************************************************* 337
**RTW** * ***** ** ******* ** * ****** * ** * * ** 310
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***RTW*H**I************1S*A** *D* *** ***L*F*H* 311
I**Q*PQ* *I****** ** R*I *DF** *QASI*SPQ* *A*V* *S 393
_ -- --- -- - -_ _ _ _ _
BON GPLTLELQIAXDKNYSYYGVGDYPVVXLLRDPIYVEVSILHRTDPSLGL 362
HRM **********************************************Y*** 387
RAB *******H**TM************TMD************************* 360
CAT ** ******************************** ***** 397
PIG ** **********ER**A************** ********** ** 361
MOU ***R***R**T**TFS***QGS***L*R***E*V****RL*Q******V* 443
BON LLHQCWATPSTDPLSQPQWPILVKGCPYIGDNYQTQLIPVQKALDLPFPS 412
M ****************************************** 437
RAB R***** ******************* ******************* 410
CAT ** ****4**-**QQ****** *** *************** **** 447
PIG H*-******GS**L*****TM****T*T******************** 411
MO * **T* **********F*******VV***F******WAAD*E-A**W* 492
FIG. 2. Comparison of the primary amino acid sequence of bonnet mon-
key ZP1 with ZP1 of 5 other species. The deduced amino acid sequence
(single-letter code) of clone 5 (BoC5) excluding the 5' -500-bp (474-nt)
repeat fragment is represented. For comparison of amino acid sequence,
amino acids E and V at positions 175 and 176, which are present in clones
23 and 25 but are deleted in clone 5, have been included. Asterisks in-
dicate completely conserved amino acids with respect to bonnet monkey
ZP1; potential N-linked glycosylation sites (Asn-Xaa-Ser/Thr) are under-
lined. The signal peptidase cleavage site and the tri-basic furin proteolytic
processing signal (Arg-Arg-Arg) are indicated by arrows and overlining,
respectively. The completely conserved amino acid residues in the six
species are marked with dashes in the space beneath the sequences. The
amino acid sequence of bonnet monkey ZP1 reported in this figure will
appear in the EMBL protein sequence database under accession numbers
Y10381 and Y10383.
BM HYIFMSIFTFSFVDPTVKRQALRGPVHLHCSVSVCQPAETPSSVRTCPDL 462
HUM ************* ** * ******** **************** 487
RAB *H***********L*SS*A***K**IY**********TG*Q*CT-***ID 459
CAT Y***********-**W* *** *3******G*S*C-****VA 495
PIG **************-S*A****** ****TA******GOA*IC-V***AA 459
MOU *****P*T**MLL*SS-SQN****Q*YFF**A*S*H*LGS*DTCST**DG 541
BOM SRRRFSTIIQNTT ---- ASVSSKGPMILLQATKDPPEKLR----APVDS 504
HUM ******DS ** ************************* V**** 529
RAB ****NSDIN**** ---- *N********** ****S*** HHSGV** * HP 505
CAT R***HSDLBHHSS*----.**I************M*SA***H SS*I** 541
PIG R***SSDIH***G*----**I************R*S*R*HKYSR*** 505
MOU IA**RR*SGHH*I*LRALDI***P*AVGFED*A*LE*SGSSRNaSRMLL 591
BOM KVLWVA-GLSGTLILGGLVVWSYLAIK-QLNCPDQTCQ 539
H1M *******************A* * * *S****** 565
RAB GA****-******I**L*****RTR--------R 533
CAT QA**N*.*******F*1************R ------- 569
PIG ****-**L*S**I*A*L****VFRR --------R 533
MOU LL*AITLA*AAGIFV*--LInAW*Q*LW ---- EGIRY 622
535
------ -- --- 
-- - --- -
-
.
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TABLE 1. Reactivity in ELISA of polyclonal antibodies generated against
r-ZP1 and r-ZP1-DT conjugate in rabbits with r-ZPI and DT.
Reactivity in ELISA (antibody units)
r-ZP1 DT*
Rabbit Immunogen Day 0 Day 35 Day 0 Day 35
Males r-ZP1
R-136 507 926672 NA NA
R-137 726 939283 NA NA
Females r-ZP1-DT
R-29 797 144610 275 484100
R-30 423 172100 200 200930
* NA, Not applicable.
FIG. 3. Electrophoretic analysis and immunoblot of cell lysates prepared
from SG13009[pREP41, which harbors the pQE-ZP1 plasmid.
SG13009[pREP4] cells transformed with the pQE-ZP1 r-plasmid were
grown until A600 = 0.7 and were induced with different concentrations of
IPTG (lanes 2-5) for 2 h. Cells were lysed by boiling for 5 min in SDS-
PAGE buffer and electrophoresed as described in the Materials and Meth-
ods. A) Coomassie-stained gel. Lane M: molecular weight marker (x
10 3); lane 1: uninduced cells; lanes 2, 3, 4, and 5: cells induced with
IPTG at a concentrations of 0.5, 1, 2, and 3 mM, respectively; lane 6:
r-ZP1 purified on Ni-NTA agarose column (eluted in buffer E). Arrows
indicate recombinant 6XHis-ZP1 fusion protein. B) Immunoblot of A, ex-
cluding lane 6, probed with MA-410.
The bonnet monkey ZP1 polypeptide chain contained 5
potential N-linked glycosylation sites (Asn-X-Ser/Thr).
Two potential cAMP- and cGMP-dependent protein kinase
phosphorylation sites at positions 249 and 469 were found
in bonnet monkey ZP1 protein. It had 7 potential protein
kinase C phosphorylation sites at positions 186, 212, 244,
245, 455, 463, and 480. The protein was also found to have
8 N-myristoylation sites at positions 111, 166, 168, 182,
268, 328, 511, and 520. The bonnet monkey ZP1 polypep-
tide was rich in leucine (11.1%), serine (10.2%), valine
(9.0%), and proline (8.3%).
The conformation of bonnet monkey ZP1 protein was
16.5% helical, 28.7% extended, and 54.7% coils as pre-
dicted by the Gascuel and Bolmard Basic Statistical Meth-
od (PCGene, IntelliGenetics, Inc.). According to the Hopp
and Woods [16] analysis, taking an average group of 6 ami-
no acid residues, three domains corresponding to amino
acid residues 492-497 (average hydrophilcity (Ah) = 2.0),
461-467 (Ah = 1.75), and 78-83 (Ah = 1.55) were ob-
served to have the highest hydrophilicity. The analysis of
the bonnet monkey ZP1 sequence further revealed two pre-
dicted transmembrane segments corresponding to
LLQCVLLCVSLSLVLSG (amino acid residues 3-19) and
VLWVAGLSGTLILGGLV (amino acid residues 506-522)
motifs [17].
Expression of ZP1 in E. coil
The 1.317-kb fragment from clone 5 corresponding to
bonnet monkey ZP1, excluding the signal sequence and the
putative transmembrane-like domain, was PCR-amplified
and cloned into pQE-30 vector. The recombinant plasmid
pQE-ZP1 was used to transform the SG13009[pREP4] bac-
terial strain. Typical results obtained by 0.1% SDS-10%
PAGE and immunoblotting from one of the transformed
clones is shown in Figure 3. The fusion protein had an
apparent molecular mass of 51 kDa. In addition, a dominant
band of 40 kDa along with intermediary products was ob-
served. The optimum expression was obtained at 0.5 mM
IPTG. The expression of ZP1 was tightly regulated as this
was not observed in the uninduced transformed bacterial
cells (Fig. 3). Higher IPTG levels seemed to inhibit growth
of transformed bacterial cells without any further increase
in expression levels of r-ZP . Cellular localization revealed
that the fusion protein was present in the insoluble intra-
cellular fraction and was not secreted in the periplasm (data
not shown). Purification of r-ZP1 on the Ni-NTA agarose
affinity matrix revealed major protein bands of 51 and 40
kDa (Fig. 3). The r-ZP1 was also expressed in BL21(plysS)
cells deficient in the ompT and on proteases. The pattern
obtained in the Western blot was comparable to that ob-
tained with SG13009(pREP4). Moreover, r-ZPI was ob-
served in absence of IPTG, suggesting that its expression
is not highly regulated.
Immunogenicity of r-ZP1
From a 2-L batch culture, approximately 15 mg of pu-
rified r-ZP1 was obtained and used to immunize male rab-
bits. Female rabbits were also immunized with r-ZPl cou-
pled to DT. Immunization of male rabbits R- 136 and R- 137
resulted in the generation of high antibody titers (926672
and 939283 antibody units, respectively) against r-ZPI (Ta-
ble 1). High antibody titers against r-ZP1 and DT were also
observed in the immunized female rabbits. However, in
contrast to the male rabbits, 5- to 7-fold lower anti-r-ZPI
antibody titers were observed in female animals.
To prove the authenticity of recombinant protein, it is
imperative to show that antiserum generated against the
r-ZP1 recognizes the native protein. Rabbit antiserum
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FIG. 4. Reactivity of rabbit anti-r-ZP1 se-
rum with bonnet monkey zona pellucida
by indirect immunofluorescence. Repre-
sentative immunofluorescence patterns are
shown. Top left, immune serum; top right,
preimmune serum (x100). Microphoto-
graphs at bottom left and bottom right rep-
resent bright field optics corresponding to
top left and top right, respectively.
against r-ZP1 showed intense fluorescence with the zona
pellucida on sections from the bonnet monkey ovary (Fig.
4). The preimmune serum failed to show any immunoflu-
orescence (Fig. 4). Moreover, the fluorescence was specific
to the zona matrix, and the antibodies did not react with
other ovarian cell types.
DISCUSSION
Active immunization of female subjects with native por-
cine ZP glycoproteins as well as the deglycosylated form
leads to a block of fertility in several animal models [18-
22]. However, to design a zona glycoprotein/protein-based
immunocontraceptive vaccine for human use, it will be de-
sirable to use either human zona proteins or those with a
high sequence homology with human zona protein. Recent
observations in cynomolgus monkeys reported the presence
of a ZPI transcript in only the oocytes of secondary folli-
cles and its absence in the primordial/primary follicles and
granulosa cells [6]. This prompted us to clone and sequence
the bonnet monkey ZP1 cDNA. A partial ZPI sequence has
also been reported from the cynomolgus monkey [23].
These investigators failed to isolate full-length ZPI cDNA
clones in spite of exhaustive screening of the two cynom-
olgus monkey ovarian cDNA libraries with a porcine ZP1
probe. An insert of 866 bp encoding a polypeptide of 270
amino acids corresponding to the C terminus and approx-
imately 50% of the expected full-length sequence has been
reported.
Comparison of 270 amino acids corresponding to cy-
nomolgus monkey ZP1 with bonnet monkey ZPI revealed
changes in only 8 amino acids, of which three occur after
the predicted furin cleavage site. Bonnet monkey ZP1 has
a tri-basic (R-R-R) cleavage site beginning at amino acid
464 that is similar to human ZPI. However, cynomolgus
monkey ZP1 has only 2 instead of 3 arginine residues. On
the basis of von Heijne's [15] scoring method, bonnet mon-
key ZPI has a potential peptidase site after the 21st amino
acid, resulting in an N terminal lysine. The polyadenylation
signal AAUAAA overlaps with the translation stop codon
UAA, thus resulting in a short (17 nucleotide) untranslated
region at the 3' end, a feature common to the mRNA from
humans, mice, rabbits, pigs, and cats. Comparison of the
deduced amino acid sequence of precursor bonnet monkey
ZP1 protein revealed the highest sequence identity with hu-
man (92.0%) and the lowest with mouse (36.9%) ZP1. The
low sequence homology of bonnet monkey ZP1 with mouse
ZP1 is attributed to elongated exons 3 and 12 of mouse
ZP1 [24]. There are 4 amino acid residues that are unique
in bonnet monkey ZP1 (at positions 2, 121, 455, and 522
of precursor bonnet monkey ZP1 protein) that are otherwise
conserved in human, pig, rabbit, cat, and mouse ZP1. There
are 5 amino acid residues, identical and unique to both
human and bonnet monkey ZP1 (77, 116, 273, 439, and
451 numbered according to the bonnet monkey ZP1 pre-
cursor protein) that otherwise are conserved in pig, rabbit,
cat, and mouse ZP1. Bonnet monkey ZP1 has 5 potential
N-glycosylation sites as compared to 6 in human ZP1, of
which 3 are conserved (Fig. 2). Interestingly, bonnet mon-
key ZP1 has 23 cysteine residues that are conserved with
respect to human ZPI. However, human ZP1 has 2 addi-
tional cysteine residues. A dendrogram (unweighted pair
group maximum averages) of the alignment of mouse, cat,
pig, rabbit, human, and bonnet monkey ZPI amino acid
sequences revealed that the bonnet monkey is closer than
the others to the human in evolution (figure not shown).
At the moment, it is not clear whether repetition of the
500-bp 5' fragment is an artifact introduced while pack-
aging cDNA into Xgtll or is due to a partial gene dupli-
cation. The 3' nucleotide sequence of the 500-bp fragment
does not match the Xgtl arm used for packaging and thus
is probably not an artifact of packaging. In chickens, pro-
gesterone receptor A and B proteins are synthesized from
the same mRNA by alternate initiation sites from two in
the frame AUG codons [25]. The chicken progesterone re-
ceptor B protein differs from the A protein by an additional
128 amino acids located at the N terminus. The evolution-
ary and functional significance of the two forms of the ste-
roid hormone receptor is unclear. Whether such a possibil-
ity of alternate initiation codon usage exists for expression
of ZPI in nonhuman primates is at best a speculation.
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To undertake feasibility studies of an immunocontracep-
tive vaccine based on bonnet monkey ZP1, it will be de-
sirable to have the antigen in a pure form without contam-
ination of other ovary-associated antigens. Bonnet monkey
ZP1 was expressed in E. coli as a 6XHis fusion protein,
allowing for its convenient purification in a truncated form
excluding the signal sequence (21 amino acid residues) and
excluding the C-terminal portion (77 amino acid residues
including the transmembrane-like domain), which is pro-
cessed by furin-like proteases. Analyzed by SDS-PAGE,
the fusion protein showed dominant bands corresponding
to 51 and 40 kDa. Expression was reasonably high (7.5
mg/L in a batch flask culture) although some amounts of
intermediary products of the expressed protein were evident
in the Western blots. The degradation of r-ZP1 was neither
eliminated nor reduced with expression of the protein in a
ion and ompT protease-deficient strain, BL21(plysS), indi-
cating that some other proteases were responsible for the
degradation observed. Alternatively, it may represent pre-
mature termination during translation of the ZP1 mRNA.
The bonnet monkey r-ZP1 was highly immunogenic in
both male and female rabbits, and anti-r-ZP1 antibodies rec-
ognized the bonnet monkey zona pellucida. Proteins ex-
pressed in a prokaryotic expression system are not glyco-
sylated. Active immunization studies with glycosylated and
deglycosylated porcine ZP antigens in the rabbit model sys-
tem have attributed ovarian pathology to glycosylation [26,
27]. Recently, cynomolgus monkeys were immunized with
the rabbit zona protein rc55 (a homologue of bonnet mon-
key ZP1) expressed in a prokaryotic expression system as
cro-13-galactosidase fusion protein and coupled to key-
hole-limpet hemocyanin/protein-A. Antibody response
against the rc55 inhibited homologous sperm-egg interac-
tion without concomitant disturbances in cyclicity or any
associated ovarian pathology [28]. Active immunization of
female bonnet monkeys and female baboons of proven fer-
tility with r-ZP1-DT conjugate are in progress to study its
efficacy for fertility regulation and effect on ovarian func-
tions.
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